Clinical Trial Update: Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 genotype-guided study of irinotecan-cisplatin for advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED